Document is current

Any future updates will be listed below

Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis

Crossref DOI link: https://doi.org/10.1136/rmdopen-2019-001091

Published Online: 2020-02-02

Published Print: 2020-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark